Literature DB >> 24568310

Histochemical investigation of Cochlospermum regium (Schrank) Pilg. leaves and chemical composition of its essential oil.

Marielle Cascaes Inácio1, Tiago Antunes Paz, Bianca Waléria Bertoni, Maria Aparecida Ribeiro Vieira, Márcia Ortiz Mayo Marques, Ana Maria Soares Pereira.   

Abstract

Essential oil from Cochlospermum regium (Schrank) Pilg. leaves (CR-EO) has been extracted by hydrodistillation; we analysed the CR-EO by gas chromatography coupled with mass spectrometry. We also conducted histochemical analysis on cross-sections of the central vein of young and adult leaves. A total of 32 compounds were qualitatively and quantitatively analysed, which represented 94.87% of the total CR-EO oil content. The CR-EO basically consisted of sesquiterpenes (96.87%); its main component was β-copaen-4-α-ol (18.73%), followed by viridiflorol (12.67%). The histochemical analyses identified the main classes of compounds present in both young and adult leaves.

Entities:  

Keywords:  Bixaceae; Cochlospermum regium; GC–MS analysis; sesquiterpenes; β-copaen-4-α-ol

Mesh:

Substances:

Year:  2014        PMID: 24568310     DOI: 10.1080/14786419.2013.879133

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

1.  Control of Cryptococcus Gattii Biofilms by an Ethanolic Extract of Cochlospermum Regium (Schrank) Pilger Leaves.

Authors:  Adriana A Almeida-Apolonio; Wellinton J Cupozak-Pinheiro; Vagner M Berres; Fabiana G S Dantas; Terezinha I E Svidzinski; Kelly M P Oliveira; Marilene R Chang
Journal:  ScientificWorldJournal       Date:  2018-06-06

2.  In Vitro Control of Uropathogenic Microorganisms with the Ethanolic Extract from the Leaves of Cochlospermum regium (Schrank) Pilger.

Authors:  Danny Ellen Meireles Leme; Allan Belarmino Rodrigues; Adriana Araújo de Almeida-Apolonio; Fabiana Gomes da Silva Dantas; Melyssa Fernanda Norman Negri; Terezinha Inez Estivalet Svidzinski; Jonas da Silva Mota; Claudia Andrea Lima Cardoso; Kelly Mari Pires de Oliveira
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-11       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.